Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials

PEGylated asparaginase (pegaspargase) can be administered via intramuscular (IM) injection or intravenous (IV) infusion with a hypersensitivity reaction (HSR) incidence ranging 3–41%. We evaluated grade ≥3 HSRs when given IM vs. IV on six Children’s Oncology Group (COG) leukemia trials (2003–2015) t...

全面介紹

Na minha lista:
書目詳細資料
發表在:Leuk Lymphoma
Main Authors: Burke, Michael J., Devidas, Meenakshi, Maloney, Kelly, Angiolillo, Anne, Schore, Reuven, Dunsmore, Kimberly, Larsen, Eric, Mattano, Len A., Salzer, Wanda, Winter, Stuart S., Carroll, William, Winick, Naomi J., Loh, Mignon L., Raetz, Elizabeth, Hunger, Stephen P., Bleyer, Archie
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5940583/
https://ncbi.nlm.nih.gov/pubmed/29115886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1397658
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍